Monoclonal gammopathy of undetermined significance
Monoclonal gammopathy of undetermined significance | |
ICD-10 | D47.2 |
---|---|
ICD-9 | 273.1 |
DiseasesDB | 1341 |
MeSH | D008998 |
Monoclonal gammopathy of undetermined significance Microchapters |
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Monoclonal gammopathy of undetermined significance On the Web |
American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance |
Monoclonal gammopathy of undetermined significance in the news |
Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance |
Risk calculators and risk factors for Monoclonal gammopathy of undetermined significance |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Omer Kamal, M.D. [2]
Synonyms and keywords: Benign monoclonal gammopathy; MGUS; monoclonal gammopathy, benign
Overview
Historical Perspective
Classification
Monoclonal gammopathy of undetermined significance (MGUS) may be classified according to cytogenetic differences into subtypes/groups based on translocations. There is no established system for the staging of Monoclonal gammopathy of undetermined significance (MGUS).
Pathophysiology
Causes
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases
Epidemiology and Demographics
Risk Factors
Common risk factors in the development of monoclonal gammopathy of undetermined significance include African american race, age, male sex, family history, history of immunosuppression and exposure to pesticides.
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies